Effectiveness of rectal displacement devices in managing prostate motion: a systematic review
- PMID: 32444903
- DOI: 10.1007/s00066-020-01633-9
Effectiveness of rectal displacement devices in managing prostate motion: a systematic review
Abstract
Purpose: To determine whether rectal displacement devices (RDDs) have a prostate-stabilizing effect during prostate external beam radiotherapy (EBRT).
Methods: A systematic literature search using the PubMed database from January 1, 2000 to December 30th, 2019 was conducted. The effect of RDDs on inter- and intra-fractional prostate displacements was extracted.
Results: From 356 articles identified via the PubMed database and hand search, 21 articles were included in the systematic review. There was no randomized study. Twelve studies evaluated the role of the endorectal balloon (ERB) in managing prostate motion. Four studies reported the effect of hydrogel spacer on prostate motion. Four studies examined the effect of the rectal retractor (RR) on intra-fractional prostate motion, and only one study assessed the impact of ProSpare (Nottinghamshire, UK) in reducing prostate motion.
Conclusion: Using an ERB significantly reduces intra-fractional prostate motion. This prostate-stabilizing effect of the ERB can translate into reduced planning target volume (PTV) margins and additional rectal dose sparing. Even with an ERB in place, inter-fractional prostate displacements are seen. As a consequence, ERB application does not obviate daily verification; however, this is not a crucial topic because pretreatment imaging is always done nowadays. As compared with ERB, the hydrogel spacer significantly reduces rectal dose and toxicity without influencing prostate immobilization. The RR can increase prostate and rectal inter- and intra-fractional stability without a clear influence on the reduction of rectal toxicity. Finally, it is unclear whether ProSpare is a suitable device reducing prostate motion. Further study will be required to clarify whether the prostate-stabilizing effects of the ERB and RR can result in a safe reduction of PTV margins and further sparing of organs at risks, especially the rectum.
Keywords: Endorectal balloon; Hydrogel spacer; ProSpare; Prostate motion; Rectal retractor.
Similar articles
-
Effectiveness of rectal displacement devices during prostate external-beam radiation therapy: A review.J Cancer Res Ther. 2021 Apr-Jun;17(2):303-310. doi: 10.4103/jcrt.JCRT_841_19. J Cancer Res Ther. 2021. PMID: 34121672 Review.
-
A comparison between hydrogel spacer and endorectal balloon: An analysis of intrafraction prostate motion during proton therapy.J Appl Clin Med Phys. 2017 Mar;18(2):106-112. doi: 10.1002/acm2.12051. Epub 2017 Feb 25. J Appl Clin Med Phys. 2017. PMID: 28300377 Free PMC article.
-
Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.Med Phys. 2012 Jun;39(6):3080-8. doi: 10.1118/1.4711813. Med Phys. 2012. PMID: 22755693
-
Impact of the use of an endorectal balloon on rectal dosimetry during stereotactic body radiation therapy for localized prostate cancer.Pract Radiat Oncol. 2016 Jul-Aug;6(4):262-267. doi: 10.1016/j.prro.2015.10.019. Epub 2015 Nov 9. Pract Radiat Oncol. 2016. PMID: 26725959
-
Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.Future Oncol. 2018 Nov;14(26):2773-2788. doi: 10.2217/fon-2018-0286. Epub 2018 Jun 25. Future Oncol. 2018. PMID: 29939069 Review.
Cited by
-
Reply to Ghaffari et al. "In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.".Radiat Oncol. 2020 Sep 9;15(1):213. doi: 10.1186/s13014-020-01659-4. Radiat Oncol. 2020. PMID: 32907601 Free PMC article. No abstract available.
-
Quality assurance and long-term stability of a novel 3-in-1 X-ray system for brachytherapy.J Appl Clin Med Phys. 2022 Sep;23(9):e13727. doi: 10.1002/acm2.13727. Epub 2022 Jul 18. J Appl Clin Med Phys. 2022. PMID: 35848090 Free PMC article.
-
Rectal retractor in prostate radiotherapy: pros and cons.Radiat Oncol. 2022 Dec 9;17(1):204. doi: 10.1186/s13014-022-02176-2. Radiat Oncol. 2022. PMID: 36494732 Free PMC article.
-
MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer.Cancers (Basel). 2021 Apr 9;13(8):1791. doi: 10.3390/cancers13081791. Cancers (Basel). 2021. PMID: 33918650 Free PMC article. Review.
-
Impact of technological advances in treatment planning, image guidance, and treatment delivery on target margin design for prostate cancer radiotherapy: an updated review.Br J Radiol. 2024 Jan 23;97(1153):31-40. doi: 10.1093/bjr/tqad041. Br J Radiol. 2024. PMID: 38263844 Free PMC article. Review.
References
-
- Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV (2009) Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys 73:685–691 - PubMed
-
- Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA et al (2014) Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8:475–487
-
- King CR, Brooks JD, Gill H, Presti JC Jr (2012) Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 82:877–882 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials